A New Resource for MPN patients

MPN Cancer Connection

 

Welcome to MPN Cancer Connection, where a brighter future for MPN treatments shines on the horizon with opportunity and resources for improved patient care.

Goals

Are Myeloproliferative Neoplasms (MPNs) Cancer?

This is one of the most frequently asked questions by newly diagnosed patients, and one not clearly understood by many hematologist at the local level. YES indeed, MPNs including Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia are blood cancers. That is why the term was changed from myeloproliferative disorder to myeloproliferative neoplasm. Check out the video below for a detail explanation by Dr. Stephen Oh.
 

What Are Myeloproliferative Neoplasms?

Myeloproliferative neoplasms (MPN) are a group of diseases that affect blood-cell formation. In all forms of MPN, a bone marrow problem leads to increased levels of blood cells circulating in the bloodstream. .
 
1) “Myelo” refers to bone marrow, which is the body’s blood-cell factory.
2) “Proliferative” refers to the rapid growth and production of cells.
3) “Myeloproliferative” means increased growth and production of bone marrow and blood cells.
4) “Neoplasm” means an abnormal growth of cells, especially as a characteristic of cancer.
 

Learn More

Learn more about MPN (Myeloproliferative Neoplasms)
David Wallace is recognized as a 2016 MPN Hero for his commitment to help newly diagnosed patients with myeloproliferative neoplasms (MPNs) learn about their condition. He founded PV Reporter and MPN Cancer Connection, an informative website and non-profit foundation that provides information and resources for MPN patients.
2018 - Update on the latest Myeloproliferative Neoplasm (MPNs) research by Dr. Ruben Mesa, Director - UT Health San Antonio Cancer Center.

Like us on Facebook!

Visit our Facebook page to receive updates on MPN Cancer Connection information, events, fundraisers, stories, and resources!

Check out the MPN Booklet, 2017

Click on the Book icon for the MPN Booklet. Myeloproliferative Neoplasm publication used with permission of The Leukemia & Lymphoma Society, 2017.

Blog

April 9, 2018
MPN research

ASH Partners with UNC, a ClinGen grantee to Curate Genomic data for Blood Research

Publisher’s Note: My source at the American Society of Hematology (ASH) informed me that “initially MPNs aren’t going to be a primary focus, however, we expect […]
March 9, 2018
MPN cells

Ruxolitinib Metformin combo: A Possible Alternative Treatment for Myeloproliferative Neoplasm Patients

Metformin demonstrates antileukemic activity and may have clinical implications for the treatment of myeloproliferative neoplasms (MPN) in combination with ruxolitinib, according to a study published in Cell Death & […]
February 22, 2018

How MPN Blood Cancers outsmart the Immune System

AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE Researchers have discovered how some of the blood cancers known as myeloproliferative neoplasms (MPNs) evade the immune system.  Their […]
WordPress Security